eGenesis brings kidney xenotransplants closer to the clinic

Ayisha Sharma

News Reporter

eGenesis’ genetically modified pig kidney transplant program reached preclinical proof-of-concept in a monkey model, and the company is in discussions with the FDA about what …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

eGenesis brings kidney xenotransplants closer to the clinic

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

In surprise, study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy

Ex-Kite leaders step in at Kyverna as CEO exits after landing year's second-biggest IPO

BioNTech rolls out Phase 2 lung cancer data as VEGF bispecifics take center stage

Pfizer tees up Phase 3 test in weight management — but in an unexpected area

Immatics loses Bristol Myers' support on Phase 1 bispecific T cell engager

Breaking down silos with a new quantitative approach to drug development

eGe­n­e­sis brings kid­ney xeno­trans­plants clos­er to the clin­ic

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

eGenesis brings kidney xenotransplants closer to the clinic